Business Description
Exact Sciences Corp
NAICS : 621511
SIC : 8731
ISIN : US30063P1057
Share Class Description:
STU:EXK: Ordinary SharesDescription
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.34 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.87 | |||||
| Debt-to-EBITDA | 47.21 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.98 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12 | |||||
| 3-Year EPS without NRI Growth Rate | 29.7 | |||||
| 3-Year FCF Growth Rate | -27.9 | |||||
| 3-Year Book Growth Rate | 7.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.13 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.55 | |||||
| 9-Day RSI | 55.97 | |||||
| 14-Day RSI | 57.29 | |||||
| 6-1 Month Momentum % | 6.93 | |||||
| 12-1 Month Momentum % | 4.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.17 | |||||
| Quick Ratio | 1.98 | |||||
| Cash Ratio | 1.42 | |||||
| Days Inventory | 67.45 | |||||
| Days Sales Outstanding | 30.35 | |||||
| Days Payable | 35.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.4 | |||||
| Shareholder Yield % | -0.79 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.19 | |||||
| Operating Margin % | -6.94 | |||||
| Net Margin % | -6.7 | |||||
| FCF Margin % | 3.6 | |||||
| ROE % | -5.59 | |||||
| ROA % | -2.71 | |||||
| ROIC % | -3.36 | |||||
| 3-Year ROIIC % | 14.04 | |||||
| ROC (Joel Greenblatt) % | -17.42 | |||||
| ROCE % | -2.63 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.01 | |||||
| PB Ratio | 4.14 | |||||
| Price-to-Operating-Cash-Flow | 110.7 | |||||
| EV-to-EBIT | -97.04 | |||||
| EV-to-Forward-EBIT | -500.92 | |||||
| EV-to-EBITDA | 256.88 | |||||
| EV-to-Forward-EBITDA | 71.78 | |||||
| EV-to-Revenue | 5.75 | |||||
| EV-to-Forward-Revenue | 4.69 | |||||
| EV-to-FCF | -1004.53 | |||||
| Price-to-Projected-FCF | 1626.75 | |||||
| Price-to-Median-PS-Value | 0.3 | |||||
| Earnings Yield (Greenblatt) % | -1.03 | |||||
| FCF Yield % | -0.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Exact Sciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,467.83 | ||
| EPS (TTM) (€) | -1.073 | ||
| Beta | 1.36 | ||
| Volatility % | 54.69 | ||
| 14-Day RSI | 57.29 | ||
| 14-Day ATR (€) | 1.563605 | ||
| 20-Day SMA (€) | 64.2395 | ||
| 12-1 Month Momentum % | 4.52 | ||
| 52-Week Range (€) | 38.145 - 68.94 | ||
| Shares Outstanding (Mil) | 184.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Exact Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Exact Sciences Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Exact Sciences Corp Frequently Asked Questions
What is Exact Sciences Corp(STU:EXK)'s stock price today?
The current price of STU:EXK is €65.07. The 52 week high of STU:EXK is €68.94 and 52 week low is €38.15.
When is next earnings date of Exact Sciences Corp(STU:EXK)?
The next earnings date of Exact Sciences Corp(STU:EXK) is 2025-02-21 Est..
Does Exact Sciences Corp(STU:EXK) pay dividends? If so, how much?
Exact Sciences Corp(STU:EXK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers